- Home
- BWFG vs EIKN Comparison
BWFG vs EIKN Comparison
Compare BWFG & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BWFG | EIKN |
|---|---|---|
| Founded | 2002 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 543.4M | 631.0M |
| IPO Year | 2014 | 2026 |
Fundamental Metrics
Financial Performance| Metric | BWFG | EIKN |
|---|---|---|
| Price | $64.67 | $10.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $55.00 | $25.60 |
| AVG Volume (30 Days) | 44.7K | ★ 463.5K |
| Earning Date | 04-22-2026 | 03-30-2026 |
| Dividend Yield | ★ 1.52% | N/A |
| EPS Growth | ★ 261.79 | N/A |
| EPS | ★ 2.95 | N/A |
| Revenue | ★ $2,826,000.00 | N/A |
| Revenue This Year | $17.64 | N/A |
| Revenue Next Year | $6.21 | N/A |
| P/E Ratio | $22.19 | ★ N/A |
| Revenue Growth | ★ 43.96 | N/A |
| 52 Week Low | $40.45 | $7.90 |
| 52 Week High | $69.59 | $16.50 |
Technical Indicators
Market Signals| Indicator | BWFG | EIKN |
|---|---|---|
| Relative Strength Index (RSI) | 45.50 | 48.99 |
| Support Level | $45.62 | $8.62 |
| Resistance Level | $69.41 | $13.85 |
| Average True Range (ATR) | 1.67 | 1.15 |
| MACD | -0.51 | -0.06 |
| Stochastic Oscillator | 22.41 | 18.51 |
Price Performance
Historical ComparisonAbout BWFG Bankwell Financial Group Inc.
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.
About EIKN Eikon Therapeutics Inc. Common Stock
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.